realtim
polymeras
chain
reaction
molecular
diagnosi
infecti
diseas
microbiolog
normal
vs
immun
compromis
clinic
laboratori
tradit
reli
timeconsum
phenotyp
method
cultur
serolog
biochem
test
detect
identif
character
microbi
pathogen
realtim
polymeras
chain
reaction
pcr
technolog
avail
identifi
mani
pathogen
organ
constitut
infecti
diseas
emerg
normal
immunecompromis
host
use
molecular
technolog
accur
diagnosi
infecti
diseas
agent
clinic
laboratori
reduc
time
diagnosi
mani
pathogen
role
molecular
diagnost
test
evalu
infecti
etiolog
rapidli
evolv
new
test
becom
avail
year
articl
discuss
variou
realtim
polymeras
chain
reaction
pcr
base
assay
antigen
detect
assay
current
avail
use
emerg
set
make
specif
microbiolog
diagnosi
serolog
assay
cultur
stain
cover
articl
emerg
set
molecular
diagnost
method
yield
sever
advantag
serolog
method
molecular
method
directli
assay
presenc
microorgan
time
specimen
obtain
ideal
acut
ill
patient
serolog
method
assay
antibodi
respons
microorgan
typic
requir
least
week
symptom
even
immunoglobulin
test
immunecompromis
immunesuppress
patient
frequent
mount
appropri
antibodi
respons
thu
serolog
assay
evalu
patient
earli
cours
diseas
test
patient
immun
dysregul
often
yield
falseneg
result
patient
treat
intraven
immunoglobulin
preced
year
typic
immunoglobulin
g
present
wide
array
infecti
agent
never
seen
lead
falseposit
serolog
test
optim
serolog
evalu
typic
requir
retest
week
infect
ie
convalesc
titer
demonstr
increas
titer
associ
tempor
recent
ill
delay
definit
diagnosi
molecular
method
also
provid
rapid
diagnosi
etiolog
possibl
cultur
result
avail
within
hour
assay
perform
local
mani
infecti
agent
grown
standard
cultur
methodolog
eg
mycoplasma
pneumonia
fastidi
eg
bordetella
pertussi
lead
frequent
falseneg
result
organ
grow
slowli
eg
mycobacterium
tuberculosi
cultur
result
avail
week
clinic
microbiolog
laboratori
afford
offer
virolog
servic
owe
high
expens
perform
tissu
cultur
labor
intens
requir
highli
skill
laboratori
personnel
purchas
tissu
cultur
cell
line
everi
week
may
use
even
avail
viru
cultur
typic
requir
day
result
depend
particular
viru
howev
vast
major
bacteri
pathogen
cultur
still
remain
gold
standard
diagnosi
typic
yield
microbiolog
diagnosi
day
follow
antibiot
suscept
result
molecular
method
assay
resist
gene
develop
organ
gener
avail
time
section
articl
organ
organ
system
like
affect
emerg
set
design
clinician
evalu
patient
sever
acut
ill
refer
relev
molecular
diagnost
avail
pertin
predomin
organ
system
involv
consider
overlap
variou
test
among
organ
system
test
present
multipl
organ
system
head
section
divid
diagnost
appropri
normal
host
addit
diagnost
pertin
immunecompromis
host
thu
diagnost
normal
host
usual
also
relev
immunecompromis
host
address
infect
variou
organ
system
brief
overview
provid
principl
behind
common
molecular
assay
current
use
diagnost
laboratori
pathogen
detect
realtim
pcr
antigen
test
specif
organ
address
appear
varieti
molecular
method
exist
diagnost
microbiolog
pcr
far
univers
methodolog
use
pathogen
detect
recent
year
realtim
pcr
also
known
quantit
pcr
qpcr
becom
goto
techniqu
clinic
laboratori
review
ref
contrast
convent
pcr
simpli
amplifi
target
dna
molecul
realtim
pcr
detect
amplifi
quantifi
target
dna
molecul
real
time
realtim
pcr
fluoresc
dye
use
label
pcr
product
thermal
cycl
realtim
pcr
instrument
measur
accumul
fluoresc
signal
exponenti
phase
reaction
rapid
precis
quantit
pcr
product
quantit
yield
absolut
number
copi
given
sequenc
rel
amount
standard
known
amount
dna
clinic
particularli
use
exampl
determin
viral
load
plasma
serum
individu
infect
human
immunodefici
viru
hiv
fluorescencebas
diagnost
realtim
pcr
assay
avail
inhous
well
commerci
approv
food
drug
administr
fda
mani
human
pathogen
review
ref
virtu
abil
simultan
detect
quantifi
seal
pcr
plate
postpcr
process
step
realtim
pcr
lend
autom
rapid
turnaround
time
reduc
human
error
addit
multiplex
realtim
pcr
assay
autom
instrument
simultan
detect
screen
varieti
pathogen
current
develop
expect
time
replac
standalon
assay
specif
pathogen
despit
excit
possibl
cost
multiplex
instrument
signific
limit
mani
smaller
clinic
laboratori
review
focus
individu
realtim
pcr
assay
current
wide
avail
diagnosi
infecti
diseas
emerg
follow
section
pathogen
organ
affect
major
organ
system
central
nervou
system
pulmonari
cardiac
gastrointestin
bloodstream
systemat
accompani
tabl
list
follow
inform
host
normal
compromis
microorgan
viral
bacteri
fungal
parasit
method
detect
antigen
realtim
pcr
specimen
type
repres
commerci
test
nation
refer
laboratori
mayo
medic
laboratori
http
www
mayomedicallaboratoriescom
quest
diagnost
wwwquestdiagnost
com
regard
nomenclatur
pcr
methodolog
pcr
denot
tabl
refer
realtim
pcr
qpcr
refer
realtim
pcr
truli
quantit
author
purpos
avoid
use
term
rtpcr
refer
realtim
pcr
reversetranscriptas
pcr
literatur
realtim
reversetranscriptas
pcr
use
virus
contain
plussens
minussens
rna
genom
influenza
viru
west
nile
viru
forth
section
focus
molecular
diagnost
pertin
evalu
infecti
caus
enceph
mening
tabl
bacteri
mening
remain
danger
treatabl
form
cerebr
spinal
fluid
csf
alway
test
bacteri
cultur
molecular
diagnost
test
inform
test
csf
identifi
presenc
genet
antigen
materi
microorgan
howev
csf
obtain
mani
test
also
perform
blood
meningoenceph
normal
host
herp
simplex
viru
hsv
enteroviru
test
becom
routin
test
csf
mani
center
bacteri
antigen
test
avail
decad
accuraci
test
remain
poor
result
limit
clinic
util
molecular
diagnost
test
unlik
yield
origin
set
postinfecti
enceph
incit
microorgan
longer
present
molecular
diagnost
test
like
greatest
util
immunecompromis
host
central
nervou
system
infect
abil
make
accur
diagnosi
via
lumbar
punctur
clinic
set
except
challeng
one
wherebi
mani
microbi
pathogen
caus
similarappear
diseas
need
rapid
diagnosi
urgent
mani
diagnost
becom
avail
fairli
recent
aid
diagnostician
meet
challeng
illustr
tabl
realtim
pcr
test
commerci
avail
mani
list
virus
bacteria
unfortun
case
bacteri
mening
molecular
techniqu
identifi
etiolog
agent
current
lack
absenc
reliabl
csf
cultur
eg
antibiot
therapi
lumbar
punctur
identif
suspect
pathogen
tradit
depend
use
assay
latex
agglutin
relat
immunochromatograph
membran
assay
direct
qualit
detect
antigen
common
bacteri
pathogen
caus
mening
eg
haemophilu
influenza
b
neisseria
meningitid
group
b
streptococcu
escherichia
coli
streptococcu
pneumonia
latex
agglutin
assay
exampl
specif
antibodi
bound
surfac
latex
particl
slide
addit
specimen
visibl
agglutin
occur
specimen
contain
bacteri
antigen
react
respect
antibodyco
latex
bead
assay
complet
depend
accumul
polysaccharid
antigen
specimen
mani
fals
neg
occur
sensit
remain
critic
issu
addit
antigen
sampl
come
organ
colon
mucos
surfac
lead
falseposit
result
immunecompromis
categori
quantit
assay
epsteinbarr
viru
ebv
cytomegaloviru
cmv
exist
extens
use
quantit
assay
pathogen
hiv
discuss
bloodstream
system
infect
section
cryptococcu
neoforman
identif
csf
reli
antigen
identif
latex
agglutin
assay
enzym
immunosorb
assay
howev
oppos
bacteri
antigen
test
cryptococc
antigen
test
prove
accur
reliabl
pathogen
list
qualit
realtim
pcr
assay
exist
identifi
pathogen
csf
blood
diagnost
test
section
focu
evalu
pneumonia
tabl
varieti
rapid
influenza
diagnost
test
ridt
avail
sever
year
provid
use
tool
emerg
urgent
care
outpati
set
detect
influenza
viru
b
ridt
immunoassay
identifi
presenc
influenza
b
nucleoprotein
antigen
clinic
specimen
qualit
fashion
test
popular
provid
result
within
minut
less
mani
commerci
avail
test
approv
officebedsid
use
disadvantag
test
includ
suboptim
test
sensit
result
falseneg
result
especi
period
influenza
activ
high
addit
although
specif
high
falseposit
result
may
also
occur
influenza
activ
therefor
pretest
probabl
low
pandem
strain
poorli
detect
standard
ridt
time
lead
develop
reversetranscript
pcr
technolog
identifi
strain
refer
standard
laboratori
confirm
influenza
viru
infect
current
viral
cultur
realtim
pcr
rapid
respiratori
syncyti
viru
rsv
antigen
detect
becom
standard
diagnost
tool
evalu
children
bronchiol
pneumonia
develop
pcr
diagnost
fastidi
organ
legionella
pneumophilia
b
pertussi
improv
abil
diagnos
pathogen
realtim
pcr
technolog
diagnos
tuberculosi
rel
new
may
prove
use
achiev
rapid
diagnosi
slowgrow
organ
acid
fast
bacillu
cultur
still
need
perform
grow
problem
drug
resist
tuberculosi
also
excit
develop
new
multiplex
assay
evalu
multipl
respiratori
pathogen
rapidli
simultan
singl
sampl
multiplex
platform
design
use
local
clinic
microbiolog
laboratori
result
avail
hour
discuss
later
tabl
list
individu
pathogen
typic
assay
multiplex
platform
variat
regard
mani
organ
test
depend
particular
platform
illustr
tabl
individu
realtim
pcr
assay
current
exist
bacteri
viral
fungal
pathogen
case
influenza
rsv
rapid
antigen
assay
verifi
realtim
pcr
given
influenza
ab
rsv
may
caus
ill
clinic
indistinguish
realtim
pcr
panel
test
includ
influenza
ab
rsv
mayo
diagnost
test
prod
consid
alreadi
mention
innov
pcrbase
multiplex
molecular
diagnost
test
current
develop
screen
multipl
respiratori
pathogen
exampl
esensor
instrument
genmark
dx
carlsbad
ca
identifi
follow
pathogen
respiratori
viral
panel
influenza
gener
influenza
season
subtyp
influenza
mexico
strain
influenza
season
subtyp
influenza
b
respiratori
syncyti
viru
subtyp
b
parainfluenza
virus
human
metapneumoviru
rhinoviru
adenovirus
b
c
e
coronavirus
current
consid
fda
approv
technolog
abil
allow
clinic
laboratori
rapidli
identifi
caus
agent
matter
hour
recent
develop
pcr
assay
pneumocysti
aspergillu
immunecompromis
host
like
improv
detect
current
technolog
section
focus
diagnost
test
evalu
infecti
origin
myocard
pericard
tabl
although
rel
rare
event
clinic
frequent
lifethreaten
emerg
normal
immunecompromis
host
enterovirus
adenovirus
common
infecti
caus
myocard
realtim
pcr
best
technolog
evalu
viremia
caus
organ
organ
also
major
one
implic
cardiac
transplant
reject
addit
toxoplasma
infect
associ
heart
transplant
well
myocard
immunecompromis
host
realtim
pcr
methodolog
current
avail
variou
pathogen
associ
cardiac
infect
except
c
neoforman
mention
earlier
current
reli
antigenbas
test
latex
agglutin
enzym
immunosorb
assay
see
tabl
diagnost
test
section
focu
infecti
caus
enter
coliti
hepat
pancreat
tabl
realtim
pcr
diagnosi
clostridium
difficil
infect
replac
standard
c
difficil
toxin
assay
mani
center
realtim
pcr
assay
avail
bacteri
enter
pathogen
typic
diagnos
standard
stool
cultur
realtim
pcr
assay
bacteri
enter
pathogen
order
panel
eg
mayo
diagnost
test
eprp
antibiot
resist
occur
salmonella
speci
particular
stool
cultur
necessari
test
antibiot
suscept
realtim
pcr
shigatoxin
produc
e
coli
use
identifi
strain
caus
hemolyt
urem
syndrom
standard
stoolcultur
techniqu
recov
enteroinvas
e
coli
assay
realtim
pcr
antigen
detect
giardia
cryptosporidium
significantli
sensit
assay
organ
standard
ovaandparasit
examin
stool
adenoviru
serotyp
associ
enter
ie
grow
standard
viral
cultur
must
assay
antigen
detect
realtim
pcr
adenoviru
grown
viral
cultur
stool
enteritiscaus
serotyp
realtim
pcr
hepat
b
hepat
c
quantit
use
diagnosi
monitor
patient
chronic
infect
pathogen
antivir
therapi
test
hepat
viru
routin
use
patient
present
develop
acut
liver
diseas
section
focus
molecular
diagnost
use
set
like
bloodstream
infect
sepsi
system
infect
tabl
set
sepsislik
ill
sever
system
ill
like
due
infecti
etiolog
bacteremia
remain
common
import
caus
thu
blood
cultur
remain
gold
standard
evalu
patient
addit
blood
cultur
molecular
diagnost
use
evalu
patient
depend
clinic
scenario
hiv
includ
section
acut
hiv
infect
ie
acut
retrovir
syndrom
present
acut
febril
ill
multipl
manifest
realtim
pcr
test
avail
multipl
tickborn
ill
rocki
mountain
spot
fever
rickettsia
rickettsii
potenti
fatal
ebv
cmv
hsv
varicella
zoster
viru
vzv
adenoviru
parvoviru
includ
immunecompromis
section
infect
typic
selflimit
normal
host
potenti
fatal
immunecompromis
host
shown
tabl
specif
realtim
pcr
assay
avail
mani
bloodstream
pathogen
unlik
detect
via
standard
blood
cultur
case
hiv
realtim
pcr
reaction
involv
initi
revers
transcript
step
hiv
retroviru
contain
bipolar
plussens
rna
genom
wellstudi
relationship
hiv
rna
copi
number
stage
hiv
diseas
efficaci
hiv
therapi
mani
truli
quantit
realtim
rtpcr
assay
exist
hiv
analyt
sensit
commonli
low
copiesml
unit
state
tick
signific
vector
infecti
diseas
rank
second
mosquito
diseas
transmiss
across
world
given
mani
differ
agent
associ
tickborn
diseas
eg
r
rickettsia
borrelia
burgdorferi
ehrlichia
spp
babesia
microti
commerci
realtim
pcr
tickborn
panel
current
avail
differenti
identifi
caus
agent
case
qualit
assay
result
report
either
neg
posit
target
organ
case
rocki
mountain
spot
fever
realtim
pcr
skin
biopsi
use
detect
etiolog
agent
acut
blood
sampl
owe
low
number
rickettsia
circul
blood
absenc
advanc
diseas
fulmin
infect
immunecompromis
categori
herpesvirus
ebv
cmv
signific
concern
transplant
recipi
quantit
realtim
pcr
assay
exist
pathogen
reliabl
detect
million
copi
per
millilit
import
recogn
may
variat
result
obtain
one
laboratori
anoth
laboratori
clinic
caus
difficulti
interpret
whether
signific
chang
viral
replic
occur
common
exampl
ebv
cmv
copi
number
report
one
institut
patient
transfer
anoth
institut
second
quantit
pcr
perform
test
becom
standard
time
less
problemat
qualit
realtim
pcr
assay
also
avail
herpesvirus
hsv
vzv
well
adenoviru
parvoviru
set
infecti
diseas
emerg
rapid
accur
identif
caus
agent
critic
optim
antimicrobi
therapi
time
manner
clearli
evid
age
molecular
diagnost
upon
us
realtim
pcr
becom
standard
diagnosi
mani
infecti
diseas
emerg
either
monoplex
multiplex
format
molecular
techniqu
whole
partial
genom
sequenc
microarray
broadrang
pcr
restrict
fragment
length
polymorph
molecular
type
also
use
howev
small
clinic
laboratori
implement
advanc
molecular
techniqu
feasibl
owe
high
cost
instrument
reagent
test
avail
inhous
sampl
sent
nation
refer
laboratori
eg
mayo
medic
laboratori
quest
diagnost
realtim
pcr
assay
complet
day
anticip
time
commerci
realtim
pcr
test
instrument
becom
standard
afford
allow
individu
laboratori
conduct
test
local
thu
reduc
turnaround
time
although
realtim
pcr
prove
expand
diagnost
capabl
must
stress
molecular
methodolog
constitut
addit
tool
diagnosi
infecti
diseas
emerg
situat
phenotyp
methodolog
stain
cultur
biochem
test
serolog
still
play
critic
role
identifi
confirm
provid
antibiot
suscept
test
mani
microbi
pathogen
multiplex
assay
becom
increasingli
avail
even
greater
temptat
take
shotgun
approach
diagnost
test
new
technolog
substitut
proper
histori
physic
examin
lead
thought
differenti
diagnosi
none
less
new
molecular
test
increas
capabl
diagnostician
rapidli
identifi
microbiolog
etiolog
infect
ad
advantag
rapid
diagnost
test
often
emphas
capabl
rule
certain
diagnos
unnecessari
antimicrobi
therapi
may
otherwis
institut
andor
continu
